We are proud to announce that INEYE THERAPEUTICS and ULS Coimbra have received approval for their joint Demonstrator Project under the COMPETE 2030 – Call MPr-2024-9 (SIID – Business R&D – Demonstrators) program.
This project represents a major step forward in validating the InEye® technology for the reduction of dry eye symptoms.
Conducted in a consortium between INEYE THERAPEUTICS and the Local Health Unit of Coimbra (ULS Coimbra), the initiative will bring the InEye® prototype closer to commercialization.
Through this demonstrator, the partners aim to showcase the InEye® technology as a more effective, practical, and sustainable alternative to existing market solutions for ocular therapy.
This approval under COMPETE 2030 strengthens INEYE THERAPEUTICS’s mission to translate advanced materials science into impactful health innovations — developed and validated in Portugal, for the world.
